Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Tissue & Cell|December 20, 2025
The dual role of autophagy in breast cancer stemness and treatment resistanceAnu Jayanthi Panicker, Kirti S Prabhu, Ummu Habeeba, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 17, 2025
PI3 K/AKT/mTOR pathway and its role in breast cancer stem cellsKirti S Prabhu, Shilpa Kuttikrishnan, Zahwa Mariyam, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 30, 2024
H2AX: A key player in DNA damage response and a promising target for cancer therapyKirti S Prabhu, Shilpa Kuttikrishnan, Nuha Ahmad, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Anticancer Potential and Molecular Targets of Pristimerin in Human MalignanciesKirti S Prabhu, Serah Jessy, Shilpa Kuttikrishnan, et al.
International Review of Cell and Molecular Biology|February 12, 2025
Nectin-4: A promising prognostic marker and therapeutic target in cancerShilpa Kuttikrishnan, Kirti S Prabhu, Ummu Habeeba, et al.
Phytotherapy Research : PTR|April 6, 2026
Sanguinarine Induces ROS-Mediated Mitochondrial Dysfunction and Inhibits AKT/GSK3 Signaling to Potentiate Apoptotic Effects in Cutaneous T-Cell LymphomaShilpa Kuttikrishnan, Muhammad Suleman, Fareed Ahmad, et al.
Cell Biology International|August 20, 2025
Targeting mTOR and Its Associated Signaling to Induce Cell Death in Breast Cancer Stem CellsKirti S Prabhu, Zahwa Mariyam, Syed A Rahman, et al.
ACS Pharmacology & Translational Science|July 15, 2026
Pristimerin Suppresses Janus Kinase/Signal Transducers and Activators of Transcription Oncogenic Signaling To Drive Mitochondrial and Caspase-Dependent Apoptosis in Multiple MyelomaZahwa Mariyam, Kirti S Prabhu, Ummu Habeeba, et al.
Toxicology and Applied Pharmacology|April 5, 2026
Pristimerin drives ROS-dependent apoptosis in cutaneous T-cell lymphoma via inhibition of the AKT-SKP2 axisShilpa Kuttikrishnan, Rasheeda Anver, Fareed Ahmad, et al.
European Journal of Pharmacology|November 7, 2025
Selective induction of apoptosis in T-cell acute lymphoblastic leukemia by pristimerin through dual PI3K/AKT pathway inhibition and ROS generationShilpa Kuttikrishnan, Zahwa Mariyam, Fareed Ahmad, et al.
Pageof 1